Retinitis Pigmentosa (Retinitis) Global Clinical Trials Review, H2, 2018

GlobalData's clinical trial report, “Retinitis Pigmentosa (Retinitis) Global Clinical Trials Review, H2, 2018" provides an overview of Retinitis Pigmentosa (Retinitis) clinical trials scenario. This report provides top line data relating to the clinical trials on Retinitis Pigmentosa (Retinitis). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

– The report provides a snapshot of the global clinical trials landscape

– Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

– The Report provides enrollment trends for the past five years

– Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

Assists in formulating key business strategies with regards to investment

Helps in identifying prominent locations for conducting clinical trials which saves time and cost

Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

Supports understanding of trials count and enrollment trends by country in global therapeutics market

Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Companies mentioned

Novelion Therapeutics Inc

Neurotech Holdings LLC

Allergan Plc

Ocugen Inc

Nacuity Pharmaceuticals Pty Ltd

jCyte Inc

Innovations In Sight LLC

Horama SA

Dompe Farmaceutici SpA ...

Novelion Therapeutics Inc

Neurotech Holdings LLC

Allergan Plc

Ocugen Inc

Nacuity Pharmaceuticals Pty Ltd

jCyte Inc

Innovations In Sight LLC

Horama SA

Dompe Farmaceutici SpA

CMAX

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Report Guidance 6

GlobalData Clinical Trials Report Coverage 7

Clinical Trials by Region ...

Table of Contents 2

List of Tables 4

List of Figures 5

Report Guidance 6

GlobalData Clinical Trials Report Coverage 7

Clinical Trials by Region 8

Clinical Trials and Average Enrollment by Country 9

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12

Top Five Countries Contributing to Clinical Trials in Europe 13

Top Countries Contributing to Clinical Trials in North America 14

Top Five Countries Contributing to Clinical Trials in Middle East and Africa 15

Top Countries Contributing to Clinical Trials in Central and South America 16

Clinical Trials by G7 Countries: Proportion of Retinitis Pigmentosa (Retinitis) to Ophthalmology Clinical Trials 17

Clinical Trials by Phase in G7 Countries 19

Clinical Trials in G7 Countries by Trial Status 20

Clinical Trials by E7 Countries: Proportion of Retinitis Pigmentosa (Retinitis) to Ophthalmology Clinical Trials 21

Clinical Trials by Phase in E7 Countries 23

Clinical Trials in E7 Countries by Trial Status 24

Clinical Trials by Phase 25

In Progress Trials by Phase 26

Clinical Trials by Trial Status 27

Clinical Trials by End Point Status 29

Subjects Recruited Over a Period of Time 30

Clinical Trials by Sponsor Type 31

Prominent Sponsors 32

Top Companies Participating in Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials 34

Prominent Drugs 36

Latest Clinical Trials News on Retinitis Pigmentosa (Retinitis) 37

May 02, 2018: miRagen Therapeutics Presents New Preclinical Data Supporting use of MicroRNA-Targeted Therapies for Ophthalmic Diseases 37

Apr 26, 2018: GenSight Biologics to Present Data on GS030 at the Annual Meeting of Association for Research in Vision and Ophthalmology Annual Meeting 37

Clinical Trial Profile Snapshots 39

Appendix 93

Abbreviations 93

Definitions 93

Research Methodology 94

Secondary Research 94

About GlobalData 95

Contact Us 95

Source 96

List of Tables

Retinitis Pigmentosa (Retinitis) Therapeutics, Global, Clinical Trials by Region, 2018* 8

Retinitis Pigmentosa (Retinitis) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* ...

Retinitis Pigmentosa (Retinitis) Therapeutics, Global, Clinical Trials by Region, 2018* 8

Retinitis Pigmentosa (Retinitis) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 9

Retinitis Pigmentosa (Retinitis) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 11

Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018* 12

Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 13

Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, North America, Top Countries, 2018* 14

Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2018* 15

Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, Central and South America, Top Countries, 2018* 16

Proportion of Retinitis Pigmentosa (Retinitis) to Ophthalmology Clinical Trials, G7 Countries (%), 2018* 17

Retinitis Pigmentosa (Retinitis) Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 19

Retinitis Pigmentosa (Retinitis) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 20

Proportion of Retinitis Pigmentosa (Retinitis) to Ophthalmology Clinical Trials, E7 Countries (%), 2018* 21

Retinitis Pigmentosa (Retinitis) Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 23

Retinitis Pigmentosa (Retinitis) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 24

Retinitis Pigmentosa (Retinitis) Therapeutics, Global, Clinical Trials by Phase, 2018* 25

Retinitis Pigmentosa (Retinitis) Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 26

Retinitis Pigmentosa (Retinitis) Therapeutics, Global, Clinical Trials by Trial Status, 2018* 27

Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, Global, by End Point Status, 2018* 29

Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 30

Retinitis Pigmentosa (Retinitis) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 31

Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 32

Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 34

Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 36

List of Figures

Retinitis Pigmentosa (Retinitis) Therapeutics, Global, Clinical Trials by Region (%), 2018* 8

Retinitis Pigmentosa (Retinitis) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, ...

Retinitis Pigmentosa (Retinitis) Therapeutics, Global, Clinical Trials by Region (%), 2018* 8

Retinitis Pigmentosa (Retinitis) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 9

Retinitis Pigmentosa (Retinitis) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 11

Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018* 12

Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 13

Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 14

Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2018* 15

Proportion of Retinitis Pigmentosa (Retinitis) to Ophthalmology Clinical Trials, G7 Countries (%), 2018* 17

Retinitis Pigmentosa (Retinitis) Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 19

Retinitis Pigmentosa (Retinitis) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 20

Proportion of Retinitis Pigmentosa (Retinitis) to Ophthalmology Clinical Trials, E7 Countries (%), 2018* 21

Retinitis Pigmentosa (Retinitis) Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 23

Retinitis Pigmentosa (Retinitis) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 24

Retinitis Pigmentosa (Retinitis) Therapeutics, Global, Clinical Trials by Phase (%), 2018* 25

Retinitis Pigmentosa (Retinitis) Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 26

Retinitis Pigmentosa (Retinitis) Therapeutics, Global, Clinical Trials by Trial Status, 2018* 27

Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, Global, by End Point Status, 2018* 29

Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 30

Retinitis Pigmentosa (Retinitis) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 31

Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 32

Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 34

Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 36

GlobalData Methodology 94

    Pricing

Discounts available for multiple report purchases.

reportstore@globaldata.com
+44 (0) 161 359 5813

Join our mailing list

Saved reports